Skip to main content

After your doctor prescribes NovoSeven® RT, you’ll get your factor from a specialty pharmacy distributor, hemophilia home care agency, or a hemophilia treatment center.

Why specialty pharmacies?

Insurance providers use specialty pharmacies because they generally have more sophisticated systems to handle the complexities of factor therapy for people with bleeding disorders.

We’re here to help.
Insurance questions? Call 1-844-668-6732 to speak with a NovoCare® Specialist.

MixPro® Demonstration Kit NovoSeven® RT (Coagulation Factor VIIa [Recombinant])

What’s in the box?

NovoSeven® RT comes in a compact package, complete with a MixPro® prefilled syringe.

The box contains:

  • Vial with NovoSeven® RT powder
  • Vial adapter
  • Prefilled syringe with diluent
  • Plunger rod

Get a Starter Kit.

We recommend you begin with a Starter Kit. It’s designed to help you learn all about mixing a dose of NovoSeven® RT. The kit includes a carrying case, introductory booklet, infusing mat, step-by-step mixing information, and a sample device so you can practice.

 

Patient Starter Kit NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) Asset card 8 duplacate image travel-case-NovoSeven® RT Ready-to-
Ready-to-Travel Case for NovoSeven® RT (Coagulation Factor VIIa [Recombinant])

Looking for a portable treatment?

NovoSeven® RT is room temperature stable before reconstitution, so you can take it along without the need for refrigeration. After mixing, you can store it at room temperature up to 3 hours before infusing, for treating when you’re on the go.

 

For complete storage information, please see Prescribing Information.

 

Do not attempt an infusion unless you have been trained by your health care provider or hemophilia treatment center

Selected Important Safety Information

What is the most important information I should know about NovoSeven® RT?

NovoSeven® RT may cause serious side effects, including:

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT

What is NovoSeven® RT?

NovoSeven® RT (coagulation Factor VIIa, recombinant) is an injectable medicine used for:

  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with a decreased or absent response to platelet transfusions
  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults with acquired hemophilia

Important Safety Information

What is the most important information I should know about NovoSeven® RT?

NovoSeven® RT may cause serious side effects, including:

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT
  • You should not use NovoSeven® RT if you have ever had allergic (hypersensitivity) reactions, including severe, whole body reactions (anaphylaxis) to NovoSeven® RT, any of its ingredients, or mice, hamsters, or cows. Signs of allergic reaction include shortness of breath, rash, itching (pruritus), redness of the skin (erythema), or fainting/dizziness

What should I tell my healthcare provider before using NovoSeven® RT?

  • Tell your healthcare provider if you have any of the following, as these may increase your risk of blood clots:
    • congenital hemophilia and are also receiving treatment with aPCCs (activated prothrombin complex concentrates)
    • are an older patient particularly with acquired hemophilia and receiving other agents to stop bleeding
    • history of heart or blood vessel diseases
  • Tell your healthcare provider and pharmacist about all the medicines you take, including all prescription and non-prescription medicines, such as over-the-counter medicines, supplements, or herbal remedies

What are the possible side effects of NovoSeven® RT?

  • The most common and serious side effects are blood clots
  • Tell your healthcare provider about any side effects that bother you or do not go away, and seek medical help right away if you have signs of a blood clot or allergic reaction

Please click here for Prescribing Information